# N-acetylcysteine in Liver Transplantation

> **NCT00736541** · NA · COMPLETED · sponsor: **Ibtesam Hilmi** · enrollment: 100 (actual)

## Conditions studied

- End Stage Liver Failure

## Interventions

- **DRUG:** N-acetylcysteine

## Key facts

- **NCT ID:** NCT00736541
- **Lead sponsor:** Ibtesam Hilmi
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-07
- **Primary completion:** 2007-04
- **Final completion:** 2008-01
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2023-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00736541

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00736541, "N-acetylcysteine in Liver Transplantation". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00736541. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*